4oyq
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==(6-isothiocyanatohexyl)benzene inhibitor complexed with Macrophage Migration Inhibitory Factor== | ==(6-isothiocyanatohexyl)benzene inhibitor complexed with Macrophage Migration Inhibitory Factor== | ||
- | <StructureSection load='4oyq' size='340' side='right' caption='[[4oyq]], [[Resolution|resolution]] 1.70Å' scene=''> | + | <StructureSection load='4oyq' size='340' side='right'caption='[[4oyq]], [[Resolution|resolution]] 1.70Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4oyq]] is a 3 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4oyq]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OYQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4OYQ FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1X2:6-ISOTHIOCYANATOHEXYLBENZENE'>1X2</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1X2:6-ISOTHIOCYANATOHEXYLBENZENE'>1X2</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4oyq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oyq OCA], [https://pdbe.org/4oyq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4oyq RCSB], [https://www.ebi.ac.uk/pdbsum/4oyq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4oyq ProSAT]</span></td></tr> | |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Disease == | == Disease == | ||
- | [ | + | [https://www.uniprot.org/uniprot/MIF_HUMAN MIF_HUMAN] Genetic variations in MIF are associated with susceptibility to rheumatoid arthritis systemic juvenile (RASJ) [MIM:[https://omim.org/entry/604302 604302]. An inflammatory articular disorder with systemic-onset beginning before the age of 16. It represents a subgroup of juvenile arthritis associated with severe extraarticular features and occasionally fatal complications. During active phases of the disorder, patients display a typical daily spiking fever, an evanescent macular rash, lymphadenopathy, hepatosplenomegaly, serositis, myalgia and arthritis. |
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/MIF_HUMAN MIF_HUMAN] Pro-inflammatory cytokine. Involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.<ref>PMID:15908412</ref> <ref>PMID:17443469</ref> |
+ | |||
+ | ==See Also== | ||
+ | *[[Macrophage inhibitory factor 3D structures|Macrophage inhibitory factor 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: Dale | + | [[Category: Large Structures]] |
- | [[Category: Gamble | + | [[Category: Dale EJ]] |
- | [[Category: Gommans | + | [[Category: Gamble AB]] |
- | [[Category: Hampton | + | [[Category: Gommans AL]] |
- | [[Category: Nakatani | + | [[Category: Hampton MB]] |
- | [[Category: Rutledge | + | [[Category: Nakatani Y]] |
- | [[Category: Smith | + | [[Category: Rutledge MT]] |
- | [[Category: Spencer | + | [[Category: Smith RAJ]] |
- | [[Category: Tyndall | + | [[Category: Spencer ES]] |
- | [[Category: Vo | + | [[Category: Tyndall JDA]] |
- | [[Category: Wilbanks | + | [[Category: Vo CT]] |
- | + | [[Category: Wilbanks SM]] | |
- | + | ||
- | + | ||
- | + |
Revision as of 12:32, 1 February 2023
(6-isothiocyanatohexyl)benzene inhibitor complexed with Macrophage Migration Inhibitory Factor
|
Categories: Homo sapiens | Large Structures | Dale EJ | Gamble AB | Gommans AL | Hampton MB | Nakatani Y | Rutledge MT | Smith RAJ | Spencer ES | Tyndall JDA | Vo CT | Wilbanks SM